BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21139572)

  • 1. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.
    Henriques A; Pitzer C; Dittgen T; Klugmann M; Dupuis L; Schneider A
    Mol Ther; 2011 Feb; 19(2):284-92. PubMed ID: 21139572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
    Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
    Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice.
    Henriques A; Pitzer C; Dupuis L; Schneider A
    BMC Neurosci; 2010 Feb; 11():25. PubMed ID: 20178614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal delivery of AAV-NDNF ameliorates disease progression of ALS mice.
    Cheng W; Huang J; Fu XQ; Tian WY; Zeng PM; Li Y; Luo ZG
    Mol Ther; 2023 Nov; 31(11):3277-3289. PubMed ID: 37766430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models.
    Lee SH; Kim S; Lee N; Lee J; Yu SS; Kim JH; Kim S
    Acta Neuropathol Commun; 2019 Jun; 7(1):96. PubMed ID: 31189468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.
    Franz CK; Federici T; Yang J; Backus C; Oh SS; Teng Q; Carlton E; Bishop KM; Gasmi M; Bartus RT; Feldman EL; Boulis NM
    Neurobiol Dis; 2009 Mar; 33(3):473-81. PubMed ID: 19135533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular delivery of HGF-expressing recombinant AAV improves muscle integrity and alleviates neurological symptoms in the nerve crush and SOD1-G93A transgenic mouse models.
    Lee SH; Lee N; Kim S; Lee J; Choi W; Yu SS; Kim JH; Kim S
    Biochem Biophys Res Commun; 2019 Sep; 517(3):452-457. PubMed ID: 31376938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2.
    Azzouz M; Hottinger A; Paterna JC; Zurn AD; Aebischer P; Büeler H
    Hum Mol Genet; 2000 Mar; 9(5):803-11. PubMed ID: 10749988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport.
    Lu YY; Wang LJ; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    Neurosci Res; 2003 Jan; 45(1):33-40. PubMed ID: 12507722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.
    Dodge JC; Treleaven CM; Fidler JA; Hester M; Haidet A; Handy C; Rao M; Eagle A; Matthews JC; Taksir TV; Cheng SH; Shihabuddin LS; Kaspar BK
    Mol Ther; 2010 Dec; 18(12):2075-84. PubMed ID: 20859261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat.
    Foust KD; Flotte TR; Reier PJ; Mandel RJ
    Hum Gene Ther; 2008 Jan; 19(1):71-82. PubMed ID: 18072858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity.
    Dodge JC; Haidet AM; Yang W; Passini MA; Hester M; Clarke J; Roskelley EM; Treleaven CM; Rizo L; Martin H; Kim SH; Kaspar R; Taksir TV; Griffiths DA; Cheng SH; Shihabuddin LS; Kaspar BK
    Mol Ther; 2008 Jun; 16(6):1056-64. PubMed ID: 18388910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAi.
    Towne C; Aebischer P
    Methods Mol Biol; 2009; 555():87-108. PubMed ID: 19495690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of scAAV9-IGF1 extends survival in SOD1
    Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
    Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS mice.
    Towne C; Setola V; Schneider BL; Aebischer P
    Mol Ther; 2011 Feb; 19(2):274-83. PubMed ID: 21102563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
    Leyton-Jaimes MF; Kahn J; Israelson A
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte Colony-Stimulating Factor Ameliorates Skeletal Muscle Dysfunction in Amyotrophic Lateral Sclerosis Mice and Improves Proliferation of SOD1-G93A Myoblasts in vitro.
    Rando A; Gasco S; de la Torre M; García-Redondo A; Zaragoza P; Toivonen JM; Osta R
    Neurodegener Dis; 2017; 17(1):1-13. PubMed ID: 27544379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.